Giovanni Brandi
Università degli Studi di Bologna
H-index: 58
Europe-Italy
Top articles of Giovanni Brandi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The synergic effect of metformin with atezolizumab/bevacizumab in masld hcc patients: a retrospective study from arte multicentric Italian dataset | Digestive and Liver Disease | A Dalbeni M Vicardi LA Natola A Auriemma B Stefanini | 2024/2/1 |
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with … | BMC cancer | Monica Niger Federico Nichetti Lorenzo Fornaro Chiara Pircher Federica Morano | 2024/4/8 |
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo … | Tumori Journal | Desirèe Speranza Elena Sapuppo Giuseppe Aprile Alessandra Auriemma Francesca Bergamo | 2024/2/7 |
Aetiology of hepatocellular carcinoma and response to immunotherapy: is the problem inherent in the classification of non-viral disease? | Digestive and Liver Disease | F Tovoli R Chen C Vivaldi P Federico A Palloni | 2024/2/1 |
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies | Scientific Reports | Giovanni Brandi Valeria Relli Marzia Deserti Andrea Palloni Valentina Indio | 2024/2/7 |
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives | Belén Toledo Chiara Deiana Fabio Scianò Giovanni Brandi Juan Antonio Marchal | 2024/4/2 | |
FOENIX-CCA4: A phase 2 study of futibatinib 20 mg and 16 mg in patients with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor 2 (FGFR2) fusions … | Teresa Macarulla Takashi Mizuno Giovanni Brandi Jin Li Ming-Huang Chen | 2024/1/20 | |
Prognostic value of microRNA-21 in intra-and extrahepatic cholangiocarcinoma after radical resection: cohort study | BJS open | Lenka NC Boyd Mahsoem Ali Annalisa Comandatore Giovanni Brandi Simona Tavolari | 2024/4 |
The impact of etiology on patterns of progression of advanced HCC | Digestive and Liver Disease | B Stefanini F Piscaglia A Dalbeni C Vivaldi P Federico | 2024/2/1 |
Efficacy and safety of atezolizumab/bevacizumab for hepatocellular carcinoma in a real-life prospective cohort: data from a multicenter collaborative study | Digestive and Liver Disease | F Tovoli C Vivaldi P Federico B Stefanini A Palloni | 2024/2/1 |
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study | Targeted Oncology | Margherita Rimini Gianluca Masi Sara Lonardi Federico Nichetti Tiziana Pressiani | 2024/5/1 |
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions | Masuko Katoh Yohann Loriot Giovanni Brandi Simona Tavolari Zev A Wainberg | 2024/2/29 | |
Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma | Digestive and Liver Disease | F Tovoli E Franceschini C Vivaldi P Federico A Palloni | 2024/2/1 |
Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study | La Medicina del lavoro | Stefania Curti Mena Gallo Daniela Ferrante Francesca Bella Lorenza Boschetti | 2024/4/24 |
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care | Digestive and Liver Disease | Benedetta Stefanini Laura Bucci Valentina Santi Nicola Reggidori Lorenzo Lani | 2024/2/9 |
Neoadjuvant chemotherapy alone or combined with trans-arterial therapies for downstaging unresectable intrahepatic cholangiocarcinoma to surgical resection: a narrative review | Francesca Caputo Matteo Serenari Andrea Palloni Matteo Ravaioli Giovanni Brandi | 2023 | |
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy | Frontiers in Oncology | Andrea Casadei-Gardini Francesco Leone Giovanni Brandi Mario Scartozzi Nicola Silvestris | 2023/4/5 |
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … | The Lancet | Robin Kate Kelley Makoto Ueno Changhoon Yoo Richard S Finn Junji Furuse | 2023/6/3 |
Diagnosis and treatment of cholangiocarcinoma in Italy: a Delphi consensus statement | Lorenza Rimassa Giovanni Brandi Monica Niger Nicola Normanno Davide Melisi | 2023/9/28 | |
Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma | Frontiers in Medicine | Cristina Nanni Cristina Mosconi Valentino Dragonetti Massimo Barakat Nicola Fraccascia | 2023 |
